Yasmin Polak
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous Xanthomatosis.
Journal: Journal of inherited metabolic disease
Published: December 24, 2025
Effectiveness and Safety of Personalized Cholic Acid Treatment in Patients With Bile Acid Synthesis Defects.
Journal: Journal of inherited metabolic disease
Published: January 10, 2025
Quality assessment of cholic acid as an active pharmaceutical ingredient: Analytical method and results.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: December 27, 2024
Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substance.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: October 02, 2024
The clinical and biochemical effectiveness and safety of cholic acid treatment for bile acid synthesis defects: a systematic review.
Journal: Orphanet journal of rare diseases
Published: May 08, 2024
Medicine compounding in the pharmacy
Journal: Nederlands tijdschrift voor geneeskunde
Published: March 17, 2023
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects.
Journal: Pharmaceutics
Published: January 10, 2023
Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic Acid.
Journal: Frontiers in pharmacology
Published: August 13, 2021
Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity.
Journal: Peptides
Published: October 11, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026